top
Search terms
Results 1 - 6 of 6 - ordered by :
Ehjournal

Within 6-month follow-up, the time to AF relapse increased on dronedarone 800mg, with a median of 60 days vs 5.3 days in the placebo group (relative risk reduction 55% [95% CI, 28 to 72%] ...

European Heart Journal, Touboul, Paul, Brugada, Josep, Capucci, Alessandro, Crijns, Harry J.G.M., Edvardsson, Nils, Hohnloser, Stefan H.

Date : 01/08/2003 Item size : 147574 bytes
Ehjournal

After a mean follow-up of 2.3±0.6 years, the primary endpoint (a composite of cardiovascular mortality, heart failure, thrombo-embolic complications (TECs), bleeding, serious adverse effects of ...

European Heart Journal, Rienstra, Michiel, Van Gelder, Isabelle C., Hagens, Vincent E., Veeger, Nic J.G.M., Van Veldhuisen, Dirk J., Crijns, Harry J.G.M.

Date : 01/02/2006
Ehjournal

Within 6-month follow-up, the time to AF relapse increased on dronedarone 800mg, with a median of 60 days vs 5.3 days in the placebo group (relative risk reduction 55% [95% CI, 28 to 72%] ...

European Heart Journal, Touboul, Paul, Brugada, Josep, Capucci, Alessandro, Crijns, Harry J.G.M., Edvardsson, Nils, Hohnloser, Stefan H.

Date : 01/08/2003 Item size : 147532 bytes
Ehjournal

After a mean follow-up of 2.3±0.6 years, the primary endpoint (a composite of cardiovascular mortality, heart failure, thrombo-embolic complications (TECs), bleeding, serious adverse effects of ...

European Heart Journal, Rienstra, Michiel, Van Gelder, Isabelle C., Hagens, Vincent E., Veeger, Nic J.G.M., Van Veldhuisen, Dirk J., Crijns, Harry J.G.M.

Date : 01/02/2006 Item size : 177452 bytes
Ehjournal

Digoxin in heart failure In the past, it was assumed that the beneficial effect of digoxin in HF was due to its (positive) inotropic properties, which were more pronounced at higher doses of the ...

European Heart Journal, van Veldhuisen, Dirk J., Van Gelder, Isabelle C., Ahmed, Ali, Gheorghiade, Mihai

Date : 21/05/2013 Item size : 162594 bytes
Ehjournal

Within 6-month follow-up, the time to AF relapse increased on dronedarone 800mg, with a median of 60 days vs 5.3 days in the placebo group (relative risk reduction 55% [95% CI, 28 to 72%] ...

European Heart Journal, Touboul, Paul, Brugada, Josep, Capucci, Alessandro, Crijns, Harry J.G.M., Edvardsson, Nils, Hohnloser, Stefan H.

Date : 01/08/2003 Item size : 170622 bytes